col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


7 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Archives of Pharmacal Research
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Aug―10 Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression Maria Razzaq, Ji Ho Han, Subramaniyam Ravichandran, Jaehyun Kim, Joon-Yong Bae, Man-Seong Park, et al. (+5)
2 [GO] 2022―Nov―28 Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms Faezeh Almasi, Wen Dang, Fatemeh Mohammadipanah, Ning Li
3 [GO] 2021―Jul―24 Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis Sujata Purja, Hocheol Shin, Ji-Yun Lee, EunYoung Kim
4 [GO] 2021―Mai―28 COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development Joowon Yim, Hee Hyun Lim, Youngjoo Kwon
5 [GO] 2021―Jan―04 Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective Choongho Lee, Won Jun Choi
6 [GO] 2021―Jan―04 Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm Chang Hoon Lee
7 [GO] 2020―Aug―01 Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19 Li Zou, Lijun Dai, Xingyu Zhang, Zhaohui Zhang, Zhentao Zhang
 [1] 

7 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec